Amid supply shortages and persistent vaccine nationalism, it could be years before COVID-19 vaccines reach billions of people in low- and middle-income countries, theInternational Rescue Committee warned today. And that inequity threatens recovery everywhere.
Slovax: COVAX, the global initiative to achieve equitable distribution, estimates vaccines will reach a max of 20% of people in low- and middle-income countries this year—and probably far fewer.
Squandered Opportunity: The US rollout is failing as a course-correction from its disastrously fragmented pandemic response. Instead, a lack of federal/state coordination and acrimony between scientists and politicians continue to hamper progress, a Washington Post deep-dive explains.
New Development: the Trump administration is expected today to announce steps to speed the US rollout by widening the priority net to anyone aged 65+ and deploying all doses instead of holding some back for second doses, Axios reports.